Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bennamoun

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Anticancer Research|November 2, 2010
Prognostic impact of microsatellite instability in colorectal cancer patients treated with adjuvant FOLFOXG Des Guetz, C Lecaille, P Mariani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 9, 2012
Panitumumab combined with irinotecan for patients with KRAS wild-type metastatic colorectal cancer refractory to standard chemotherapy: a GERCOR efficacy, tolerance, and translational molecular studyT André, H Blons, M Mabro, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Anticancer Research|November 2, 2010
Prognostic impact of microsatellite instability in colorectal cancer patients treated with adjuvant FOLFOXG Des Guetz, C Lecaille, P Mariani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 9, 2012
Panitumumab combined with irinotecan for patients with KRAS wild-type metastatic colorectal cancer refractory to standard chemotherapy: a GERCOR efficacy, tolerance, and translational molecular studyT André, H Blons, M Mabro, et al.
Pageof 2